ONCOSYNE AS
Developing cancer treatments using patient-derived 3D tumoroid models.
Overview
- 6
- Employees
- 4.4M NOK
- Revenue
- 2020
- Founded
Key Decision Makers
Jarle Bruun
CEO and Co-founder
Peter W. Eide
CTO and Co-founder
Aarti Kapoor
Strategic Partnerships Director
Janne Nestvold
Business Advisor
+8 more contacts in Funnelfeedr
Description
Oncosyne operates at the forefront of precision oncology, utilizing its proprietary iCAN tumoroid platform. This platform creates living, patient-derived 3D tumor models that accurately mimic the characteristics of a patient's original cancer. For the pharmaceutical industry, Oncosyne offers compreh...